// App-Quantinova.ai

BSH19‐PO‐111 : Light chain amyloidosis as a rare complication of solid organ transplantation

Researchers

Presenter

  • F.A. Sharpley

Principal Investigators

  • H.J. Lachmann

Medical Centers

  • National Amyloidosis Centre, UCL Medical School, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

  • Autoimmune (AI)

  • Infectious Diseases (ID)

  • Urology

  • Endocrine/metabolic Diseases (ME)

  • Nephrology

  • Gastroenterology (GU)

  • Genetic Disorder

  • Oncology (ONC)

Disease

  • Lupus

  • Polycystic kidney disease

  • Primary biliary cirrhosis

  • AL Amyloidosis

  • Interstitial nephritis

  • Monoclonal gammopathy

  • Vesicoureteral reflux

  • Glomerulonephritis

  • Cystic Fibrosis

  • IgA nephropathy

  • Renal disease

  • Amyloid disease

  • Cirrhosis

  • Nephritis

  • Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis

  • Post-transplant lymphoproliferative disorder

Biomarkers

  • Cluster of differentiation 79A

Drug/Treatment

  • Mycophenolic acid

  • Lenalidomide

  • Cyclosporine A

  • Thalidomide

  • Bortezomib

  • Tacrolimus

  • Melphalan

  • Lanthanum carbonate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved